Leukapheresis Market Forecast Highlights Expansion From $77.69 Billion To $104.27 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Leukapheresis Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The size of the leukapheresis market has experienced notable growth in recent times. It is projected to increase from $72.02 billion in 2025 to $77.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. This expansion during the historical period can be linked to factors such as a rise in hematologic disorders, broader cancer research initiatives, greater adoption of apheresis within blood centers, improvements in centrifugation technologies, and enhanced funding for clinical research.
The leukapheresis market is anticipated to experience robust expansion over the coming years, projected to reach $104.27 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.6%. This forecasted growth is driven by several key factors, including the expansion of CAR-T and cell-based therapies, heightened investment in immunology research, a growing need for personalized medicine, the scaling up of biopharmaceutical manufacturing, and progress in apheresis automation technologies. Emerging trends likely to shape this period include the growing application of leukapheresis in cell and gene therapies, heightened demand for immune cell collection in oncology, wider implementation of automated apheresis devices, its increasing use in clinical research, and a stronger emphasis on patient-safe, disposable apheresis kits.
Download A Free Sample Report For Comprehensive Market Insights:
Leukapheresis Market Expansion Drivers: What Is Shaping Future Growth?
The anticipated increase in autoimmune diseases is set to drive expansion in the leukapheresis market. These disorders occur when the immune system erroneously attacks healthy tissues in the body. Factors such as diminished microbial exposure in early childhood and contemporary environmental influences are disrupting immune equilibrium, resulting in a greater prevalence of autoimmune conditions. Leukapheresis addresses this by selectively eliminating harmful white blood cells that trigger the immune system’s assault on the body’s own tissues. For example, in September 2025, GetValue.co, a digital platform based in the United States, reported that autoimmune diseases impact an estimated 3–10% of the global population, which translates to roughly 600–800 million individuals worldwide. Consequently, the rising incidence of autoimmune diseases is fueling the growth of the leukapheresis market.
Leukapheresis Market Segments: Where Are The Largest Growth Opportunities?
The leukapheresis market covered in this report is segmented –
1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers
Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes
Leukapheresis Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading players in the leukapheresis industry are prioritizing innovations like the creation of GMP-grade leukopaks to boost the quality and effectiveness of cell therapy production. These leukopaks are derived from leukapheresis and manufactured under rigorous good manufacturing practice (GMP) guidelines, guaranteeing that the collected cells retain high viability and functionality for therapeutic use. A case in point is Sanguine Biosciences, a US biotechnology firm, which introduced LeukoCer in November 2024—a GMP-grade leukopak aimed at simplifying processes and speeding up the development of cell therapies. Available as fresh whole or half packs, LeukoCer supplies top-tier starting materials produced in compliance with strict GMP protocols, thus enabling researchers to progress their work and accelerate the launch of new cell therapies.
Leukapheresis Market Major Participants And Competitive Dynamics
Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories
Access The Complete Leukapheresis Market Report:
Leukapheresis Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
